Kwaliteitsstandaard atypische parkinsonismen

Pagina 239 50. Visser, M., et al., Clinical tests for the evaluation of postural instability in patients with parkinson's disease. Arch Phys Med Rehabil, 2003. 84 (11): p. 1669-74. 51. Morales-Briceño H, R.-V.M., Martinez-Ramirez D, Cervantes-Arriaga A. , A reappraisal of the ten steps test for identifying atypical parkinsonism. . Clin Neurol Neurosurg., 2014 119 : p. 1-3. 52. Lee, Y.H., et al., Urinary Dysfunctions and Post-Void Residual Urine in Typical and Atypical Parkinson Diseases. J Parkinsons Dis, 2018. 8 (1): p. 145-152. 53. Yamamoto T, A.M., Yamanaka Y, Uchiyama T, Hirano S, Fuse M, Koga Y, Sakakibara R, Kuwabara S. , Postvoid residual predicts the diagnosis of multiple system atrophy in Parkinsonian syndrome. . J Neurol Sci. , 2017 15 : p. 381:230-234. . 54. Reimann M, S.C., Herting B, Prieur S, Junghanns S, Schweitzer K, Globas C, Schoels L, Reichmann H, Berg D, Ziemssen T. , Comprehensive autonomic assessment does not differentiate between Parkinson's disease, multiple system atrophy and progressive supranuclear palsy. J Neural Transm (Vienna), 2010 117 (1) : p. 69-76. . 55. Treglia, G. and E. Cason, Meta-analysis on MIBG scintigraphy in differential diagnosis between Parkinson's disease and neurodegenerative parkinsonism. Parkinsonism Relat Disord, 2012. 18 (6): p. 805; author reply 806. 56. Treglia, G., et al., MIBG scintigraphy in differential diagnosis of Parkinsonism: a meta-analysis. Clin Auton Res, 2012. 22 (1): p. 43-55. 57. Radicati, F.G., et al., Non motor symptoms in progressive supranuclear palsy: prevalence and severity. NPJ Parkinsons Dis, 2017. 3 : p. 35. 58. Pontieri, F.E., et al., Sad and happy facial emotion recognition impairment in progressive supranuclear palsy in comparison with Parkinson's disease. Parkinsonism Relat Disord, 2012. 18 (7): p. 871-5. 59. Vodusek, D.B., How to diagnose MSA early: the role of sphincter EMG. J Neural Transm (Vienna), 2005. 112 (12): p. 1657-68. 60. Sakakibara, R., et al., Sphincter EMG as a diagnostic tool in autonomic disorders. Clin Auton Res, 2009. 19 (1): p. 20-31. 61. Pellicano, C., et al., Neuropsychiatric and cognitive profile of early Richardson's syndrome, Progressive Supranuclear Palsy-parkinsonism and Parkinson's disease. Parkinsonism Relat Disord, 2017. 45 : p. 50-56. 62. Chandiramani, V.A., J. Palace, and C.J. Fowler, How to recognize patients with parkinsonism who should not have urological surgery. Br J Urol, 1997. 80 (1): p. 100-4. 63. Ekker MS, J.S., Seppi K, Poewe W, de Vries NM, Theelen T, Nonnekes J, Bloem BR., Ocular and visual disorders in Parkinson's disease: Common but frequently overlooked. Parkinsonism Relat Disord. , 2017 40 : p. 1-10. 64. Ghika, J. and J. Bogousslavsky, Presymptomatic hypertension is a major feature in the diagnosis of progressive supranuclear palsy. Arch Neurol, 1997. 54 (9): p. 1104-8. 65. Fanciulli, A., et al., Supine hypertension in Parkinson's disease and multiple system atrophy. Clin Auton Res, 2016. 26 (2): p. 97-105. 66. Mathias, C.J., R. Mallipeddi, and K. Bleasdale-Barr, Symptoms associated with orthostatic hypotension in pure autonomic failure and multiple system atrophy. J Neurol, 1999. 246 (10): p. 893-8. 67. Jordan, J., et al., Contrasting actions of pressor agents in severe autonomic failure. Am J Med, 1998. 105 (2): p. 116-24. 68. D. Robertson, K.L.M., H.F. Morrelli Treatment of cardiovascular disorders: orthostatic hypotension. Clinical Pharmacology Basic Principles in Therapeutics, , . 1992, New York: McGraw-Hill. 69. R. Freeman, D.R., P.A. Low, R.J. Polinsky, Midodrine and other pressor drugs. Primer on the Autonomic Nervous System . 1996, San Diego: Academic Press. 70. Abate, G., et al., Effects of indomethacin on postural hypotension in Parkinsonism. Br Med J, 1979. 2 (6203): p. 1466-8. 71. Imaizumi, T., et al., Increase in reflex vasoconstriction with indomethacin in patients with orthostatic hypotension and central nervous system involvement. Br Heart J, 1984. 52 (5): p. 581-4. 72. Massey, L.A., et al., Conventional magnetic resonance imaging in confirmed progressive supranuclear palsy and multiple system atrophy. Mov Disord, 2012. 27 (14): p. 1754-62.